key: cord-0756752-gbqa5uiy
authors: Borud, Einar Kristian; Nakstad, Espen Rostrup; Håberg, Siri Eldevik; Lind, Andreas; Fadum, Elin Anita; Taxt, Arne Michael; Steens, Anneke; Gjein, Gaute Eriksen; Sunde, Magne Wiken; Iversen, Petter; Svanevik, Marius; Ahmad, Babar Mushtaq; Waldow, Thomas; Norheim, Arne Johan
title: Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts
date: 2021-01-15
journal: Health Sci Rep
DOI: 10.1002/hsr2.233
sha: 5297ef4e51e916609a032fde35fe514cf22974bf
doc_id: 756752
cord_uid: gbqa5uiy

BACKGROUND: Accurate estimates of SARS‐CoV‐2 infection in different population groups are important for the health authorities. In Norway, public infection control measures have successfully curbed the pandemic. However, military training and service are incompatible with these measures; therefore extended infection control measures were implemented in the Norwegian Armed Forces. We aimed to describe these measures, discuss their value, and investigate the polymerase chain reaction (PCR) prevalence and seroprevalence of SARS‐CoV‐2, as well as changes in antibody titer levels over the 6‐week military training period in a young, asymptomatic population of conscripts. METHODS: In April 2020, 1170 healthy conscripts (median age 20 years) enrolled in military training. Extended infection control measures included a pre‐enrollment telephone interview, self‐imposed quarantine, questionnaires, and serial SARS‐CoV‐2 testing. At enrollment, questionnaires were used to collect information on symptoms, and SARS‐CoV‐2 rapid antibody testing was conducted. Serial SARS‐CoV‐2 PCR and serology testing were used to estimate the prevalence of confirmed SARS‐CoV‐2 and monitor titer levels at enrollment, and 3 and 6 weeks thereafter. RESULTS: At enrollment, only 0.2% of conscripts were SARS‐CoV‐2 PCR‐positive, and seroprevalence was 0.6%. Serological titer levels increased nearly 5‐fold over the 6‐week observation period. Eighteen conscripts reported mild respiratory symptoms during the 2 weeks prior to enrollment (all were PCR‐negative; one was serology‐positive), whereas 17 conscripts reported respiratory symptoms and nine had fever at enrollment (all were PCR‐ and serology‐negative). CONCLUSIONS: The prevalence of SARS‐CoV‐2 was less than 1% in our sample of healthy Norwegian conscripts. Testing of asymptomatic conscripts seems of no value in times of low COVID‐19 prevalence. SARS‐CoV‐2 antibody titer levels increased substantially over time in conscripts with mild symptoms.

The prevalence of SARS-CoV-2 was less than 1% in our sample of healthy Norwegian conscripts. Testing of asymptomatic conscripts seems of no value in times of low COVID-19 prevalence. SARS-CoV-2 antibody titer levels increased substantially over time in conscripts with mild symptoms.

adolescents, Armed Forces, conscripts, coronavirus, COVID-19, prevalence, SARS-CoV-2, serological analyses, serology, youths 1 | INTRODUCTION Current knowledge suggests that children and young adults infected with SARS-CoV-2 are more often asymptomatic, or have fewer and milder symptoms than older patients. [1] [2] [3] Moreover, children and teens between 10 and 19 years of age may be more likely to spread the virus among family members than adults and younger children. 4 Polymerase chain reaction (PCR) testing is mainly performed on symptomatic patients, those in need of hospitalization, patients at risk, and among health care workers. So far, SARS-CoV-2 testing has not been performed systematically in asymptomatic groups, thus the prevalence and rate of transmission in young asymptomatic individuals are still largely unknown. Accurate estimates of infection within different population groups are crucial for health authorities when deciding how and when to close and reopen societies during the COVID-19 pandemic.

Military service in Norway is mandatory for all men and women; between 7000 and 8000 of them undergo military conscription every year. 5 In order to ensure redundancy, enrollment of new conscripts is a continuous process in the Norwegian Armed Forces. In Norway, public infection control measures have successfully curbed the rates of hospital admissions and deaths due to COVID-19. 6 However, military training and service are not compatible with these measures, as service personnel live together in barracks, and combat training involves body contact. Therefore, in mid-April 2020, the Norwegian Armed Forces implemented extended infection control measures to ensure the continuation of military training and the health of military personnel. The measures included a pre-enrollment telephone interview, self-imposed quarantine before enrollment, questionnaires, and serial SARS-CoV-2 PCR and serology testing during the initial 6-week training period. We aimed to describe these measures, discuss their value, and investigate the PCR prevalence and seroprevalence of SARS-CoV-2, as well as changes in antibody titer levels over the 6-week military training period in a young, asymptomatic population of conscripts.

The study cohort included 1170 healthy conscripts (median age: 20 years, range 18-25), 798 men (68.2%) and 372 women (31.8%), who enrolled in military training between 19 and April 27, 2020. As conscripts are called for military service regardless of residential area, our cohort included men and women from all over Norway.

Two weeks prior to enrollment, conscripts were interviewed by telephone to motivate them for military service and ensure compliance with public infection control measures related to COVID-19. All conscripts were encouraged to undergo self-imposed quarantine until enrollment.

On enrollment day, conscripts underwent an initial screening:

they were asked about current respiratory symptoms, their body temperature was measured using an ear thermometer, and a sample was taken for rapid antibody testing (performed on site). Individuals with symptoms, a temperature ≥38.0 C, and/or a positive rapid antibody test underwent further clinical interviews and examinations, and were then quarantined pending the results of a PCR test ( Figure 1 ).

All conscripts also completed an online questionnaire, which col- (Table 1) , while none were rapid antibody test-negative and serologypositive. Using the serological test at Oslo University Hospital as the gold standard, the sensitivity of the SARS-CoV-2 rapid antibody test was calculated to be 100%. Of the 56 conscripts who were SARS-CoV-2 rapid antibody test-positive, 49 were serology-negative, whereas 1114 were both serology-negative and rapid antibody testnegative. Therefore, a total of 1163 were serology-negative, and the specificity of the SARS-CoV-2 rapid antibody test was calculated to be 96%. In this cohort, which had a seroprevalence at enrollment of 0.6%, the positive predictive value of the rapid antibody test was calculated to be 13%.

In the online questionnaire, 18 conscripts (1.5%) reported mild respiratory symptoms during the 2 weeks prior to enrollment.

Reported symptoms included runny nose and sneezing (72%), stuffy nose (61%), cough (55%), sore throat (33%), headaches (33%), shortness of breath (16%), fever (13%), reduced sense of taste or smell (11%), sore muscles (11%), and dizziness (6%). None of these 18 conscripts reported any respiratory symptoms on enrollment day. None was SARS CoV-2 PCR-positive at enrollment, but one was serology-positive. Nine conscripts (0.8%) answered "yes" to the question "Do you think you have had COVID-19?". Among these, one was SARS-CoV-2 PCR-positive and four were serology-positive at enrollment.

Two of the 1170 conscripts were SARS-CoV-2 PCR-positive at enrollment, and one conscript who was initially PCR-negative tested positive at week 6 ( Table 1) . None of these individuals reported any symptoms during the 2 weeks prior to enrollment, at enrollment, or during the observation period. However, during additional clinical interviews, the two conscripts who were PCR-positive at enrollment reported illness with symptom onset 4 and 7 weeks prior to enrollment, respectively. The individual who tested positive at week 6 had not been ill, and experienced no symptoms before or during the 6-week observation period.

During the 6-week observation period, a total of eight conscripts were SARS CoV-2 serology-positive, one female, and seven males. Seven conscripts (0.6%) were SARS-CoV-2 serology-positive at enrollment (Table 1) , including the three who were also PCR-positive, and one was SARS-CoV-2 PCR-negative and serology-negative at enrollment, but developed positive and rising titers at weeks 3 and 6. None of these eight conscripts had fever or reported respiratory symptoms at enrollment, nor did they report any respiratory symptoms during the observation period. One reported mild respiratory symptoms during the 2 weeks prior to enrollment. However, based on the additional clinical interview, six of the eight SARS-CoV-2 serology-positive conscripts had been ill with symptom onset 3 to 7 weeks before enrollment (Table 1) . Antibody titers increased almost 5-fold during the 6-week observation period in all but one of the eight SARS-CoV-2 serology-positive conscripts (Table 1 and 

The sensitivity and specificity of the rapid antibody test used in this study were 100% and 96%, respectively. The relatively large proportion Table 1 to 5% in European countries. 13 Our results indicate that the prevalence of COVID-19 among young, asymptomatic adults in Norway is less than 1%, which is in agreement with recent mathematical estimates from the Norwegian Institute of Public Health. 6 Six of eight seropositive conscripts, among whom two were also SARS-CoV-2 PCR-positive, had a history of symptoms compatible with COVID-19, with symptom onset between 3 and 7 weeks before enrollment. Their titer levels increased nearly 5-fold over the 6-week observation period, but they reported no new symptoms. Most people infected with SARS-CoV-2 display an antibody response between 10 and 14 days after infection; however, the antibody response may depend on disease severity. 14 In some mild cases, antibody detection is only possible long after symptom onset, and in a few cases, antibodies are not detected at all, at least not during the time scale of the reported studies. 15 The duration of antibody response is still unknown, but it is known that antibodies to other coronaviruses wane over time (range: 12-52 weeks from the onset of symptoms). 15 One study found that SARS-CoV-2 IgM and IgG antibody levels may remain for 7 weeks after symptom onset. 16 The symptoms and disease reported by the aforementioned six seropositive conscripts were mild. COVID-19 is generally considered a mild disease in adolescents. 2, 3, 17 One of the questions that requires further study is to what extent young COVID-19 patients actually present with no symptoms at all, which may increase the risk of spreading the virus to others. Our study confirms that symptoms are generally mild among young adults, but hardly supports the idea of frequent occurrence of asymptomatic spreaders; at least not in Norway. 1 

Testing of asymptomatic conscripts in our study cohort did not identify any individuals suspected of active transmission, as both conscripts who were PCR-positive at enrollment had been symptom-free for more than 20 days when they were tested. Seven of the eight conscripts with a positive serology result during the observation period had been symptom-free for at least 14 days before enrollment.

Testing of symptomatic conscripts, on the other hand, is widely recommended, 18 and is used as both as a diagnostic tool and a screening method to detect cases of COVID-19 in areas with active outbreaks. Asymptomatic testing does not seem justified, given the low prevalence and corresponding low predictive value of tests in this cohort of young healthy conscripts.

The prevalence of SARS-CoV-2 was less than 1% in our sample of healthy Norwegian conscripts. Self-reported symptoms and questionnaires may prove useful in detecting COVID-19, especially in combination with symptom-based testing. Asymptomatic testing seems of no value in times of low COVID-19 prevalence. SARS-CoV-2 antibody titer levels increased substantially over time in young adults with relatively mild symptoms.

The study is funded by the Norwegian Armed Forces. The funding source had no role in study design, collection, analysis, and interpretation of data; writing of the report; nor the decision to submit the report for publication.

None of the authors declares any conflict of interest.

Einar Kristian Borud declares that the manuscript is an honest, accu- Einar Kristian Borud had full access to all of the data in the study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis.

Author approval: All authors have agreed on the order in which their names are listed in the article.

The data that support the findings of this study are available from the Norwegian Armed Forces Health Registry. Restrictions apply to the availability of these data, which were used under license for this study.

Einar Kristian Borud https://orcid.org/0000-0001-7848-7662

Presumed asymptomatic carrier transmission of COVID-19

COVID-19 -a mild disease in children

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention

Contact tracing during coronavirus disease outbreak

Forsvarets aarsrapport 2020

COVID-19 weekly report from the Norwegian Institute of Public Health

Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system

Forskrift om innsamling og behandling av opplysninger i Forsvarets helseregister. Oslo: The Royal Norwegian Ministry of Defense

Evaluation of 17 rapid tests for detection of antibodies against SARS-CoV-2. Oslo: Norwegian Organization for Quality Improvement of Laboratory Examinations

Predicting infectious SARS-CoV-2 from diagnostic samples

Interpreting diagnostic tests for SARS-CoV-2

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv

The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection

Profile of specific antibodies to SARS-CoV-2: the first report

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Testkriterier for koronavirus (coronavirus)